Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
AstraZeneca enters strategic immuno-oncology collaboration with Celgene Corporation to develop PD-L1 inhibitor programme for patients with serious blood cancers
-
AstraZeneca PLC first quarter results 2015
-
AstraZeneca and Bina collaborate to deploy genomic management solution in R&D
-
Selumetinib granted Orphan Drug Designation by US FDA for treatment of uveal melanoma
-
AstraZeneca announces updated progression free survival data for investigational non-small cell lung cancer medicine AZD9291
-
Medimmune and Immunocore announce new collaboration to conduct immuno-oncology combination trials in melanoma
-
Tremelimumab granted Orphan Drug Designation by US FDA for treatment of malignant mesothelioma
-
FDA Advisory Committee reviews SAVOR outcomes study results for ONGLYZA® (saxagliptin) and KOMBIGLYZE® XR (saxagliptin and metformin HCI extended-release)
-
AstraZeneca to showcase strong oncology science at American Association for Cancer Research Annual Meeting 2015
-
AstraZeneca and PatientsLikeMe announce global research collaboration
Latest articles and press releases
All of our latest press releases and articles are available to explore
